166 related articles for article (PubMed ID: 23999831)
1. Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.
Weng T; Xie Y; Huang J; Luo F; Yi L; He Q; Chen D; Chen L
J Bone Miner Res; 2014 Apr; 29(4):820-9. PubMed ID: 23999831
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
[TBL] [Abstract][Full Text] [Related]
3. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.
Wang Y; Wan C; Deng L; Liu X; Cao X; Gilbert SR; Bouxsein ML; Faugere MC; Guldberg RE; Gerstenfeld LC; Haase VH; Johnson RS; Schipani E; Clemens TL
J Clin Invest; 2007 Jun; 117(6):1616-26. PubMed ID: 17549257
[TBL] [Abstract][Full Text] [Related]
4. Activation of HIFa pathway in mature osteoblasts disrupts the integrity of the osteocyte/canalicular network.
Zuo GL; Zhang LF; Qi J; Kang H; Jia P; Chen H; Shen X; Guo L; Zhou HB; Wang JS; Zhou Q; Qian ND; Deng LF
PLoS One; 2015; 10(3):e0121266. PubMed ID: 25806791
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model.
Bader HL; Hsu T
BMC Cancer; 2016 Oct; 16(1):797. PubMed ID: 27733136
[TBL] [Abstract][Full Text] [Related]
6. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
[TBL] [Abstract][Full Text] [Related]
7. Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss.
Zhao Q; Shen X; Zhang W; Zhu G; Qi J; Deng L
Bone; 2012 Mar; 50(3):763-70. PubMed ID: 22193550
[TBL] [Abstract][Full Text] [Related]
8. Oxygen sensing and osteogenesis.
Wang Y; Wan C; Gilbert SR; Clemens TL
Ann N Y Acad Sci; 2007 Nov; 1117():1-11. PubMed ID: 18056033
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
[TBL] [Abstract][Full Text] [Related]
10. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
11. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas.
Pantuck AJ; An J; Liu H; Rettig MB
Cancer Res; 2010 Jan; 70(2):752-61. PubMed ID: 20068166
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF/heme-oxygenase-1 pathway.
Zhang LF; Qi J; Zuo G; Jia P; Shen X; Shao J; Kang H; Yang H; Deng L
PLoS One; 2014; 9(6):e99946. PubMed ID: 24940620
[TBL] [Abstract][Full Text] [Related]
14. Vhl deficiency in osteocytes produces high bone mass and hematopoietic defects.
Loots GG; Robling AG; Chang JC; Murugesh DK; Bajwa J; Carlisle C; Manilay JO; Wong A; Yellowley CE; Genetos DC
Bone; 2018 Nov; 116():307-314. PubMed ID: 30172741
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
16. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
17. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the von Hippel-Lindau gene causes sympathoadrenal cell death and impairs chemoreceptor-mediated adaptation to hypoxia.
Macías D; Fernández-Agüera MC; Bonilla-Henao V; López-Barneo J
EMBO Mol Med; 2014 Dec; 6(12):1577-92. PubMed ID: 25385837
[TBL] [Abstract][Full Text] [Related]
19. Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling.
Champion KJ; Guinea M; Dammai V; Hsu T
Cancer Res; 2008 Jun; 68(12):4649-57. PubMed ID: 18559510
[TBL] [Abstract][Full Text] [Related]
20. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.
Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S
Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
